Skip to content
10-Q

Quarterly Report

Milestone Pharmaceuticals Inc. MIST

0001558370-25-007648

← back to feed
Filed
May 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 14, 2025 53.46M sh
Long Term Debt Q1 2025 · Mar 31, 2025 $54.29M
Long Term Debt Q1 2025 · Dec 31, 2024 $53.35M
Short Term Investments Q1 2025 · Mar 31, 2025 $10.87M
Short Term Investments Q1 2025 · Dec 31, 2024 $44.38M
Cash And Equivalents Q1 2025 · Mar 31, 2025 $45.09M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $25.31M
Current Liabilities Q1 2025 · Mar 31, 2025 $12.96M
Current Liabilities Q1 2025 · Dec 31, 2024 $8.13M
Total Liabilities Q1 2025 · Mar 31, 2025 $68.01M
Total Liabilities Q1 2025 · Dec 31, 2024 $62.35M
Current Assets Q1 2025 · Mar 31, 2025 $60.48M
Current Assets Q1 2025 · Dec 31, 2024 $73.93M
Total Assets Q1 2025 · Mar 31, 2025 $61.89M
Total Assets Q1 2025 · Dec 31, 2024 $75.5M
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$8.93M
Stockholders Equity Q1 2025 · Mar 31, 2024 $39.92M
Stockholders Equity Q1 2025 · Dec 31, 2023 $16.77M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.21
Eps Basic Q1 2025 · Mar 31, 2024 −$0.21
Sga Expense Q1 2025 · Mar 31, 2024 $3.95M
Rd Expense Q1 2025 · Mar 31, 2024 $3.64M
Net Income Q1 2025 · Mar 31, 2024 −$10.35M
Operating Income Q1 2025 · Mar 31, 2024 −$10.48M